Friulimicin A

Friulimicin A, a formidable antibiotic widely employed in the biomedicine sector, showcases its prowess in fierce bacterial infection warfare. Its efficacy reaches paramount heights primarily against the relentless onslaught of Gram-positive bacteria, triumphing even over those harbouring resistant properties. Fathomably distinctive in its modus operandi, Friulimicin A emerges as the panacea for diverse maladies inflicted by bacterial pathogens, spanning cutaneous afflictions, respiratory dilemmas, and urogenital predicaments.

Online Inquiry

CAT#R1987
CAS302327-40-8
M.F/FormulaC58H92N14O19
M.W/Mr.1289.43
Quick Inquiry
×
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Customer Support & Price Inquiry

* Please kindly note that our products and services can only be used to support research purposes (Not for clinical use).

Creative Peptides has accumulated a huge library of peptide knowledge including frontier peptide articles, application of peptides, useful tools, and more!

Since the discovery of Substance P (SP) in the early 1930s, its pharmacological actions have been extensively studied. SP has ...

 Propofol, known as 2,6-Diisopropyl phenol, is mainly used in the induction and maintenance of general anesthesia ...

 NoxA1ds is derived from a peptide whose structure is based on a short sequence of an essential Nox subunit. It b ...

In the respiratory tract, there are tachykinin P (SP) and neurokinin A (NKA) in capsaicin-sensitive primary affe ...

 GRK2i, a GRK2 inhibitory polypeptide, specifically inhibits Gβγ activation of GRK2. It corresponds to the Gβγ-bi ...

Contact Us

USA

Address:

Tel: |

Email:

Germany

Address:

Copyright © 2024 Creative Peptides. All rights reserved.